Goldilocks Therapeutics, Inc. — Form D

Goldilocks Therapeutics, Inc. of BEDFORD, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-20. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-04-20
• Form: D
• Accession: 0001856420-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.2M
• Amount sold: $1.2M
• Investors: 23
• Date of first sale: 2019-12-11
• Security types: equity, debt
• Revenue range: Decline to Disclose
• SEC file number: 021-396368

Issuer

• Name: Goldilocks Therapeutics, Inc.
• CIK: 0001856420
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 55 E. FIELD DRIVE, BEDFORD, NY, 10506
• Phone: (914) 205-3862

Officers, directors & promoters (4)

More

• CIK 1856420 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search